MagnetisMM-32
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Near Add Your Location
Sorting 24 by
- Accepting patients
West Penn Hospital (Allegheny Health Network)
Pittsburgh, PA
- Accepting patients
Infirmary Cancer Care
Mobile, AL
- Accepting patients
- Accepting patients
City of Hope
Goodyear, AZ
- Accepting patients
Sanford Roger Maris Cancer Center
Fargo, ND
- Accepting patients
- Accepting patients
Community Health Network - South
Indianapolis, IN
- Accepting patients
Houston Methodist Hospital
Houston, TX
- Accepting patients
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.